Thus, we introduced specifically designed primers targeting miR‐1246 and the product of RNU2‐1 degradation, revealing that exosomal miR‐1246 is mostly derived from RNU2‐1 degradation in CRC, consistent with prior findings. The gene discussed is RNU2-1; the disease is colorectal carcinoma.